Bookmark Add to Calendar

Medical Device Risk Management Following ISO 14971:2019

4975
Duration : 60 Minutes

Edwin Waldbusser, Medical Device

Ed retired from industry after 30 years in management of development of medical device products and development of company Quality Systems. He was involved in the development of products such as IVD devices, kidney dialysis systems and inhalation devices. His QS experience includes, design control, risk analysis, CAPA, softwa Read more


The US FDA expects that as part of a product development Design Control Program risk management will be conducted. FDA also expects that a post-production risk management program is implemented. FDA recommends using ISO 14971 as a guide and has accepted it as a recognized standard. Hazard Analysis is described in ISO 14971. This is the most powerful of the risk management techniques because it considers risks in normal operation as well as fault conditions. FMEA and FTA consider only fault conditions and are more suited as reliability tools than as product safety tools.

In this webinar, we will explain in detail the process of conducting a hazard analysis. The confusing terms “hazard”, hazardous situation”, “harm”, “causative event”, “ALARP”, “risk index”, “benefit/ risk ratio”, and “residual risk” will be explained. We will go step by step through a template for risk analysis so that the process is clear. Examples of hazards and hazardous situations will be discussed. How to deal with residual risk will be discussed.

We will explain how to integrate Human Factors studies into the Hazard Analysis and how to integrate Hazard Analysis into the design program. Risk level can determine the extent of CAPA investigations, validations effort, etc. Application of ISO 14971 principles to software risk management will be explained. Requirements for each step of the risk management process, including the risk management plan, development of risk acceptability criteria, risk analysis, risk evaluation, risk control, risk/ benefit analysis, postproduction analysis will be explained.

Why Should You Attend:

FDA expects that as part of a product development program risk management will be conducted and risks will be mitigated as far as practical. Risk Analysis is required in an FDA product submission. FDA recommends using ISO 14971 as a guide and has accepted it as a recognized standard. Hazard Analysis, described in ISO 14971, is the most powerful of the risk management tools, but it is very confusing. Many new concepts are introduced. We will explain these concepts and provide examples so that you can expertly perform the process. Templates will be provided. Handouts are hazard analysis forms and the HA report template.

Course Outline:

• Explanation of Hazard Analysis terms: hazard, hazardous situation, harm, risk, acceptability criteria, benefit/ risk ratio
• Explanation of the hazard analysis process using a template
• Examples of terms will be given
• Hazard analysis examples will be covered step by step
• Risk management plan
• Risk management file

What You Get:

• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points

Who Will Benefit:

• Engineering Personnel
• Engineering Manager
• Manufacturing manager
• Regulatory Personnel
• Quality Personnel

Please reach us at 1-888-844-8963 for any further assistance or if you wish to register

100% MONEY BACK GUARANTEED

Refund / Cancellation policy

Get In Touch

Subject : Medical Device Risk Management Following ISO 14971:2019


Similar Trainings

3-hr Virtual Seminar: Technical Writing for the Pharmaceutical, Medical Device and Biotech Industries
LIVE : Scheduled on 25-April-2024 :01:00 PM EDT
Human Factors-Usability Based on ISO 62366
LIVE : Scheduled on 26-April-2024 :01:00 PM EDT
Understanding the Five Pillars of 5S for Operators
LIVE : Scheduled on 29-April-2024 :01:00 PM EDT
Medical Device - Engineering Change Control
LIVE : Scheduled on 02-May-2024 :01:00 PM EDT
paypal payment Comodo

Copyright ©2024 Signup Training. All rights reserved.